Q2 2026 13F · SEC CIK 728618
Metropolitan Life Insurance Co/NY
Insurance companyFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $357.4M
- Reported positions
- 11
- Top holdings a year, 3 yrs
- +17.1%
- Average holding period
- 6.7 yrs
Metropolitan Life Insurance Co/NY is an insurance company that reported 11 positions worth $357.4M in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Spdr S&p 500 ETF Tr (SPY, 38.6%), Ishares Tr (AGG, 24.2%), Vanguard Bd Index Fds (BLV, 11.6%). A portfolio copying its top holdings returned 17.1% a year over the last 3 years, against 20.4% for the S&P 500.
Metropolitan Life Insurance Co/NY holdings all 11 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
| Stock | % of 13F value | Share change | Reported value |
|---|---|---|---|
| SPYSpdr S&p 500 ETF Tr | 38.6% | -1.1% | $137.8M |
| AGGIshares Tr | 24.2% | +3.1% | $86.5M |
| BLVVanguard Bd Index Fds | 11.6% | +0.0% | $41.3M |
| IWMIshares | 10.2% | +0.0% | $36.5M |
| EEMIshares | 3.9% | +0.0% | $13.9M |
| EFAiShs MSCI EAFE | 3.4% | +0.0% | $12.1M |
| VCSHVanguard Scottsdale Fds | 2.0% | +0.0% | $7.2M |
| VGSHVanguard Short-Term Treasury ETF Total | 2.0% | +0.0% | $7.2M |
| QQQInvesco Qqq Tr | 1.4% | -14.8% | $5.1M |
| SCHDSchwab Strategic Tr | 1.4% | +4.8% | $5.1M |
| HYGIshares Trust | 1.4% | +0.0% | $4.8M |
What Metropolitan Life Insurance Co/NY bought and sold in Q2 2026, against Q1 2026.
New positions
No new positions among the largest holdings.
Added to
No position grew by more than 5%.
Reduced
- QQQ Invesco Qqq Tr-14.8% shares
Sold out
Nothing sold out.
Share counts compared with the Q1 2026 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- +11.3% /yr
- S&P 500 +20.1%
- 3 years
- +17.1% /yr
- S&P 500 +20.4%
- 5 years
- —
A portfolio of the filer's 20 largest 13F positions, weighted by value and rebuilt each quarter on the day the filing became public. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $357.4M | 11 |
| Q1 2026 | $328.3M | 11 |
| Q4 2025 | $329.7M | 11 |
| Q3 2025 | $341.3M | 11 |
| Q2 2025 | $334.6M | 11 |
| Q1 2025 | $216.2M | 8 |
| Q4 2024 | $252.3M | 10 |
| Q3 2024 | $281.4M | 10 |
| Q2 2024 | $253.4M | 10 |
| Q1 2024 | $2.3B | 2,307 |
| Q4 2023 | $2.1B | 2,343 |
| Q3 2023 | $1.9B | 2,398 |
Questions about Metropolitan Life Insurance Co/NY's portfolio
What stocks does Metropolitan Life Insurance Co/NY own?
Metropolitan Life Insurance Co/NY's latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 11 positions worth $357.4M. The largest are Spdr S&p 500 ETF Tr (SPY) at 38.6%, Ishares Tr (AGG) at 24.2%, Vanguard Bd Index Fds (BLV) at 11.6%, Ishares (IWM) at 10.2% and Ishares (EEM) at 3.9%.
What did Metropolitan Life Insurance Co/NY buy last quarter?
Metropolitan Life Insurance Co/NY opened no new positions and grew none by more than 5% among its largest holdings in Q2 2026.
What did Metropolitan Life Insurance Co/NY sell last quarter?
In Q2 2026, Metropolitan Life Insurance Co/NY Invesco Qqq Tr (QQQ) (-14.8% shares), compared with its Q1 2026 filing.
How has Metropolitan Life Insurance Co/NY's portfolio performed?
A portfolio copying Metropolitan Life Insurance Co/NY's 20 largest 13F holdings each quarter, from the day each filing was public, returned +17.1% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +11.3% against +20.1%.
When is Metropolitan Life Insurance Co/NY's next 13F filing due?
13F filings are due 45 days after each quarter ends. Metropolitan Life Insurance Co/NY's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.